Cheshenko N et al, Commun Biol 2022
Read MoreStart typing to search for blog entry:
Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference→
/Fels JM et al, Cold Spring Harb Mol Case Stud 2022
Read MoreA Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice→
/Malonis RJ et al, PLoS Pathog 2022
Read MoreInduction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals→
/Muena N et al, EBiomedicine 2022
Read MoreHuman antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses→
/Mittler E et al, Science Transl Med 2022
Read MoreGenotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies→
/Haslwanter D et al, Cell Host Microbe 2022
Read MoreEfficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial→
/Ortigoza MB et al, JAMA Internal Med 2022
Read MoreLongitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes→
/Lasso G et al, PLoS Comput Biol 2022
Read MoreStructural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies→
/Mishra AK et al, Science 2022
Read More